Targeted ablation of Par-4 reveals a cell type-specific susceptibility to apoptosis-inducing agents

Cancer Res. 2006 Apr 1;66(7):3456-62. doi: 10.1158/0008-5472.CAN-05-0964.

Abstract

The prostate apoptosis response-4 (Par-4) protein has been shown to function as an effector of cell death in response to various apoptotic stimuli, and down-regulation of this protein has been suggested to be a key event during tumorigenesis. Several studies suggest an essential function for the COOH-terminal leucine repeats/death domain of Par-4 in mediating apoptosis. We investigated the biological role of this domain in vivo by generating knock-out mice expressing a Par-4 mutant protein lacking the COOH terminus domain. We found that the Par-4 mutant mice are viable and fertile with no overt phenotype, thus excluding an essential role for the COOH terminus domain of Par-4 in embryogenesis and developmental apoptosis. To determine the requirement of Par-4 for apoptosis, we treated primary fibroblasts with various stimuli that trigger mitochondria and membrane receptor cell death pathways. Fibroblasts isolated from Par-4 mutant mice are as sensitive as the wild-type cells to these apoptosis-inducing agents. Similar effects were observed following RNA interference (RNAi)-mediated knockdown of Par-4 in these cells. In contrast, RNAi-mediated depletion of Par-4 in HeLa cells resulted in a significant inhibition of apoptosis induced by various proapoptotic agents. Taken together, our findings provide strong genetic evidence that the proapoptotic function of Par-4 is dependent on the cellular context and raise the possibility that alterations of Par-4 function may occur during carcinogenesis.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Apoptosis / drug effects*
  • Apoptosis / genetics
  • Apoptosis / physiology*
  • Apoptosis Regulatory Proteins / deficiency*
  • Apoptosis Regulatory Proteins / genetics
  • Apoptosis Regulatory Proteins / physiology*
  • Calcimycin / pharmacology
  • Doxorubicin / pharmacology
  • Etoposide / pharmacology
  • Fibroblasts / cytology
  • Fibroblasts / drug effects
  • HeLa Cells
  • Humans
  • Ionomycin / pharmacology
  • Mice
  • Mice, Knockout
  • Protein Structure, Tertiary
  • RNA Interference
  • Staurosporine / pharmacology

Substances

  • Apoptosis Regulatory Proteins
  • prostate apoptosis response-4 protein
  • Calcimycin
  • Ionomycin
  • Etoposide
  • Doxorubicin
  • Staurosporine